GlassScriptPhysician profile
John G Petraco
NPI 1497739064
$1,060.52
in general payments reported to CMS, 2019-2025
16 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.45 · 2020: $31.85 · 2021: $75.79 · 2022: $71.27 · 2023: $89.98 · 2024: $380 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $217.82 | 2020-2025 | Evenity, Prolia, Prolia |
| Daiichi Sankyo INC. | $178.85 | 2023-2025 | Injectafer |
| Mayne Pharma Commercial LLC | $150.14 | 2022-2025 | |
| Astellas Pharma US INC | $93.15 | 2024-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $74.11 | 2019-2025 | |
| Abbvie INC. | $69.00 | 2024 | |
| Coopersurgical, INC. | $54.15 | 2021-2024 | Paragard T 380a |
| Hologic Sales and Service, LLC | $44.23 | 2019 | |
| Merck Sharp & Dohme LLC | $38.50 | 2021 | |
| Idorsia Pharmaceuticals US INC | $35.00 | 2023 | Quviviq |
| Thd America, INC. | $28.42 | 2025 | |
| Pfizer INC. | $23.70 | 2025 | |
| Shield Therapeutics INC | $23.23 | 2024 | |
| Pacira Therapeutics, INC. | $13.70 | 2020 | |
| Alydia Health | $9.43 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $7.09 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Petraco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.